Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 111 record(s)

Req # A-2020-18441

Copies of all reports, briefing notes, policy briefs, PowerPoints, emails (to and from Mitchell Levine) and other similar documents discussing the origin and adoption of pharmacoeconomics into the PMPRB guidelines from June 1, 2019 to November 19, 2020.

Organization: Patented Medicine Prices Review Board Canada

230 page(s)
January 2021

Req # A-2020-19861

Copies of all reports, briefing notes, policy briefs, PowerPoints, emails (to, from and cc'ing Douglas Clark) and other similar documents discussing the origin and adoption of pharmacoeconomics into the PMPRB guidelines from June 1, 2019 to December 9, 2020. Include, but do not limit the scope of the request to, reports discussing the origin and adoption of the QALY.

Organization: Patented Medicine Prices Review Board Canada

208 page(s)
January 2021

Req # A-2020-18432

Copies of the daily calendar meetings, calls and other taskings for Mitchell Levine from June 1, 2019 to November 18, 2020.

Organization: Patented Medicine Prices Review Board Canada

84 page(s)
December 2020

Req # A-2020-18434

Copies of all completed Access to Information requests: A-2018-001, A-2018-002, A-2018-003, A-2018-004 and A-2019-0003.

Organization: Patented Medicine Prices Review Board Canada

1978 page(s)
December 2020

Req # A 2020_0002

Hand written notes, emails and minutes of the June 2019 CDEV Board meeting approving $12.6 billion construction costs for the Trans Mountain expansion referred to in Q3 2019 Interim Report.

Organization: Canada Development Investment Corporation

4 page(s)
November 2020

Req # A 2019_0006

Copies of written reports and financial information sent to the head of CDEV and/or to the Minister of Finance between Jan. 1, 2019 and Sept. 11, 2019, related to Canada TMP Finance Limited and/or Trans Mountain Corporation. Please exclude likely cabinet confidences. Exclude HR policies, board controls and reports that have already been made public.

Organization: Canada Development Investment Corporation

154 page(s)
October 2020

Req # A 2020_0005

A copy of the Memorandum of Understanding between CDEV and the Department of Natural Resources Canada regarding the Net Profit Interest and Incidental Net Profits Interest (NPI) related to the Hibernia oil project.

Organization: Canada Development Investment Corporation

5 page(s)
September 2020

Req # A-2020-00004

List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
September 2020

Req # A-2020-04135

Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

79 page(s)
September 2020

Req # A-2020-01436

Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.

Organization: Patented Medicine Prices Review Board Canada

20 page(s)
August 2020
Date modified: